LEXICON PHARMACEUTICALS, INC. Intangible Assets, Net (Excluding Goodwill)
LEXICON PHARMACEUTICALS, INC. (LXRX) had Intangible Assets, Net (Excluding Goodwill) of $0 as of 2020-09-30, per its 10-Q filed 2020-10-30.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization
us-gaap:IntangibleAssetsNetExcludingGoodwill · last filed 2020-10-30
- 2020-09-30: Intangible Assets, Net (Excluding Goodwill) $0.00.
- 2020-06-30: Intangible Assets, Net (Excluding Goodwill) $18.83M.
- 2020-03-31: Intangible Assets, Net (Excluding Goodwill) $19.27M.
- 2019-12-31: Intangible Assets, Net (Excluding Goodwill) $19.72M.
| Period end | Intangible Assets, Net (Excluding Goodwill) | Intangible Assets, Net (Excluding Goodwill) as first filed |
|---|---|---|
| 2020-09-30 | $0.00 10-Q · filed 2020-10-30 | |
| 2020-06-30 | $18.83M 10-Q · filed 2020-07-29 | |
| 2020-03-31 | $19.27M 10-Q · filed 2020-04-27 | |
| 2019-12-31 | $19.72M 10-Q · filed 2020-10-30 | |
| 2019-09-30 | $20.16M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $49.24M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $49.68M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $50.12M 10-Q · filed 2019-11-07 | |
| 2018-09-30 | $50.56M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $51.00M 10-Q · filed 2018-07-30 | |
| 2018-03-31 | $51.44M 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $51.88M 10-Q · filed 2018-11-01 | |
| 2017-09-30 | $52.33M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $52.77M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $24.70M 10-Q · filed 2020-10-30 | $53.21M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $53.36M 10-Q · filed 2017-11-08 | |
| 2016-09-30 | $53.36M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $53.36M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $53.36M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $53.36M 10-Q · filed 2016-11-07 | |
| 2015-09-30 | $53.36M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $53.36M 10-Q · filed 2015-08-07 | |
| 2015-03-31 | $53.36M 10-Q · filed 2015-05-05 | |
| 2014-12-31 | $53.36M 10-Q · filed 2015-11-09 | |
| 2014-09-30 | $53.56M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $53.56M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $53.56M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $53.56M 10-Q · filed 2014-11-06 | |
| 2013-09-30 | $53.56M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $53.56M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $53.56M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $53.56M 10-Q · filed 2013-11-12 | |
| 2012-09-30 | $53.56M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $53.56M 10-Q · filed 2012-08-02 | |
| 2012-03-31 | $53.56M 10-Q · filed 2012-05-03 | |
| 2011-12-31 | $53.56M 10-Q · filed 2012-11-07 | |
| 2011-09-30 | $53.56M 10-Q · filed 2011-11-01 | |
| 2011-06-30 | $53.56M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $53.56M 10-Q · filed 2011-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |